News and Activities
Hot Off The Press.
Press Releases
New Study Shows Straticyte™ More Accurate Than Dysplasia Grading
Toronto, ON; February 2, 2017 - A newly published study shows Straticyte better defines the risk for developing oral squamous cell carcinoma than histopathological dysplasia grading alone. The study “Individualized Five-Year Risk Assessment for Oral Pre-malignant Progression to Cancer”was just...
Government of Canada Provides Further Support to Proteocyte Diagnostics for Straticyte
Toronto, ON; November 21, 2016 - Proteocyte Diagnostics Inc. announced new support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) for their novel prognostic oral cancer laboratory service. This continued support and technological advisory services...
Straticyte™ offers an objective assessment and may revolutionize patient care
Toronto, ON; June 16, 2016 - A New Look at Oral Dysplasia, recently published in Oral Health, recognizes the need for a more effective biomarker for oral premalignant lesions. The article highlights Straticyte’s more objective assessment capability that may revolutionize patient care. Written by...
Straticyte™ Wins a Best Poster Award at Inaugural Global Oral Cancer Forum
Toronto, ON; March 23, 2016 - Proteocyte’s Chief Scientific Officer, Dr. Ranju Ralhan, was invited to participate in the first ever Global Oral Cancer Forum to present a poster: Early Detection of Oral Lesions with Dysplasia at High Risk of Cancer Development Using A Proteomic Signature Image...